Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1996 6
1997 2
1998 3
1999 3
2000 4
2001 2
2002 2
2003 9
2004 7
2005 1
2006 3
2007 3
2008 8
2009 7
2010 9
2011 13
2012 6
2013 6
2014 4
2015 9
2016 19
2017 26
2018 29
2019 26
2020 20
2021 19
2022 14
2023 18
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

253 results

Results by year

Filters applied: . Clear all
Page 1
Striated duct adenoma: The cytological description of a rare entity.
De La Torre Serrano M, Alarcón García L, Colino Gallardo AM, Vega-Gonzalez J, Bergillos Giménez MR, Hernandez Martinez D, Garcia Egido A, Iglesias Moreno MC, Pérez-Alonso P, Plaza Hernandez JC, Fernández-Aceñero MJ. De La Torre Serrano M, et al. Among authors: fernandez acenero mj. Cytopathology. 2024 Sep 9. doi: 10.1111/cyt.13441. Online ahead of print. Cytopathology. 2024. PMID: 39248044
Prognostic Influence of Galectin-1 in Gastric Adenocarcinoma.
Díaz Del Arco C, Estrada Muñoz L, Cerón Nieto MLÁ, Molina Roldán E, Fernández Aceñero MJ, García Gómez de Las Heras S. Díaz Del Arco C, et al. Among authors: fernandez acenero mj. Biomedicines. 2024 Jul 7;12(7):1508. doi: 10.3390/biomedicines12071508. Biomedicines. 2024. PMID: 39062081 Free PMC article.
Correction: Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells.
Rio-Vilariño A, Cenigaonandia-Campillo A, García-Bautista A, Mateos-Gómez PA, Schlaepfer MI, Del Puerto-Nevado L, Aguilera O, García-García L, Galeano C, de Miguel I, Serrano-López J, Baños N, Fernández-Aceñero MJ, Lacal JC, Medico E, García-Foncillas J, Cebrián A. Rio-Vilariño A, et al. Among authors: fernandez acenero mj. Br J Cancer. 2024 May;130(8):1414. doi: 10.1038/s41416-024-02667-x. Br J Cancer. 2024. PMID: 38575733 Free PMC article. No abstract available.
Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells.
Rio-Vilariño A, Cenigaonandia-Campillo A, García-Bautista A, Mateos-Gómez PA, Schlaepfer MI, Del Puerto-Nevado L, Aguilera O, García-García L, Galeano C, de Miguel I, Serrano-López J, Baños N, Fernández-Aceñero MJ, Lacal JC, Medico E, García-Foncillas J, Cebrián A. Rio-Vilariño A, et al. Among authors: fernandez acenero mj. Br J Cancer. 2024 May;130(8):1402-1413. doi: 10.1038/s41416-024-02649-z. Epub 2024 Mar 11. Br J Cancer. 2024. PMID: 38467828 Free PMC article.
253 results